177 related articles for article (PubMed ID: 38515237)
1. Nucleic acid-based vaccine for ovarian cancer cells; bench to bedside.
Al-Hawary SIS; Jasim SA; Hjazi A; Oghenemaro EF; Kaur I; Kumar A; Al-Ani AM; Alwaily ER; Redhee AH; Mustafa YF
Cell Biochem Funct; 2024 Mar; 42(2):e3978. PubMed ID: 38515237
[TBL] [Abstract][Full Text] [Related]
2. Comparison of DNA and mRNA vaccines against cancer.
Jahanafrooz Z; Baradaran B; Mosafer J; Hashemzaei M; Rezaei T; Mokhtarzadeh A; Hamblin MR
Drug Discov Today; 2020 Mar; 25(3):552-560. PubMed ID: 31843577
[TBL] [Abstract][Full Text] [Related]
3. Nucleic acid vaccines-based therapy for triple-negative breast cancer: A new paradigm in tumor immunotherapy arena.
Saleh RO; Ibrahim FM; Pallathadka H; Kaur I; Ahmad I; Ali SHJ; Redhee AH; Ghildiyal P; Jawad MA; Alsaadi SB
Cell Biochem Funct; 2024 Apr; 42(3):e3992. PubMed ID: 38551221
[TBL] [Abstract][Full Text] [Related]
4. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
5. Development of Therapeutic Vaccines for Ovarian Cancer.
Chow S; Berek JS; Dorigo O
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33167428
[TBL] [Abstract][Full Text] [Related]
6. Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities.
Ghattas M; Dwivedi G; Lavertu M; Alameh MG
Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960236
[TBL] [Abstract][Full Text] [Related]
7. mRNA vaccine for cancer immunotherapy.
Miao L; Zhang Y; Huang L
Mol Cancer; 2021 Feb; 20(1):41. PubMed ID: 33632261
[TBL] [Abstract][Full Text] [Related]
8. Application of Traditional Vaccine Development Strategies to SARS-CoV-2.
Rando HM; Lordan R; Lee AJ; Naik A; Wellhausen N; Sell E; Kolla L; ; Gitter A; Greene CS
mSystems; 2023 Apr; 8(2):e0092722. PubMed ID: 36861991
[TBL] [Abstract][Full Text] [Related]
9. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.
Zuckermann FA; Martin S; Husmann RJ; Brandt J
Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035
[TBL] [Abstract][Full Text] [Related]
10. [Production of antiviral vaccines using a silkworm-baculovirus expression system].
Kusakabe T
Nihon Yakurigaku Zasshi; 2022; 157(2):128-133. PubMed ID: 35228445
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.
Cavanagh D
Avian Pathol; 2003 Dec; 32(6):567-82. PubMed ID: 14676007
[TBL] [Abstract][Full Text] [Related]
12. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
[TBL] [Abstract][Full Text] [Related]
13. Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses.
Brentville VA; Metheringham RL; Daniels I; Atabani S; Symonds P; Cook KW; Vankemmelbeke M; Choudhury R; Vaghela P; Gijon M; Meiners G; Krebber WJ; Melief CJM; Durrant LG
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32561639
[TBL] [Abstract][Full Text] [Related]
14. Clinical and immunological effects of mRNA vaccines in malignant diseases.
Heine A; Juranek S; Brossart P
Mol Cancer; 2021 Mar; 20(1):52. PubMed ID: 33722265
[TBL] [Abstract][Full Text] [Related]
15. Advancements in protein nanoparticle vaccine platforms to combat infectious disease.
Butkovich N; Li E; Ramirez A; Burkhardt AM; Wang SW
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1681. PubMed ID: 33164326
[TBL] [Abstract][Full Text] [Related]
16. Nucleic acid vaccination strategies for ovarian cancer.
Saha C; Bojdo J; Dunne NJ; Duary RK; Buckley N; McCarthy HO
Front Bioeng Biotechnol; 2022; 10():953887. PubMed ID: 36420446
[TBL] [Abstract][Full Text] [Related]
17. Cancer immunotherapy beyond immune checkpoint inhibitors.
Marin-Acevedo JA; Soyano AE; Dholaria B; Knutson KL; Lou Y
J Hematol Oncol; 2018 Jan; 11(1):8. PubMed ID: 29329556
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer vaccines; A comprehensive and updated review.
Al-Hawary SIS; Saleh EAM; Mamajanov NA; S Gilmanova N; Alsaab HO; Alghamdi A; Ansari SA; Alawady AHR; Alsaalamy AH; Ibrahim AJ
Pathol Res Pract; 2023 Sep; 249():154735. PubMed ID: 37611432
[TBL] [Abstract][Full Text] [Related]
19. New Approaches for Immune Directed Treatment for Ovarian Cancer.
Hardwick N; Frankel PH; Cristea M
Curr Treat Options Oncol; 2016 Mar; 17(3):14. PubMed ID: 26942589
[TBL] [Abstract][Full Text] [Related]
20. Advances and prospects of mRNA vaccines in cancer immunotherapy.
Liu Y; Yan Q; Zeng Z; Fan C; Xiong W
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189068. PubMed ID: 38171406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
